TCG Advisors’s Pfizer PFE Stock Holding History

TCG Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,523	Closed	-$544K	–	92
2020 Q2	$544K	Buy	17,523 +3,420	+24%	+$116K	0.3%	78
2020 Q1	$437K	Sell	14,103 -20,465	-59%	-$697K	0.36%	74
2019 Q4	$1.28M	Buy	34,568 +891	+3%	+$31.7K	0.77%	37
2019 Q3	$1.15M	Buy	33,677 +20,433	+154%	+$743K	0.83%	35
2019 Q2	$556K	Buy	13,244 +2	+0%	+$79	0.51%	60
2019 Q1	$534K	Buy	+13,242	New	+$530K	0.49%	59

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCG Advisors's PFE Position: Q3 2020 in Review

TCG Advisors sold out of Pfizer (PFE) in Q3 2020, closing a stake of 17,523 shares — an estimated $544K sold.

TCG Advisors first reported a position in PFE in Q1 2019 and held it in 6 quarters. The position peaked at $1.28M in Q4 2019. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

TCG Advisors reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
TCG Advisors sold 17,523 Pfizer shares in Q3 2020, an estimated $544K.
TCG Advisors first reported a position in Pfizer in Q1 2019 and held it in 6 quarters.
TCG Advisors's Pfizer position peaked at $1.28M in Q4 2019.
2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on TCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.